National Institute of Neurological Disorders and Stroke; Amended Notice of Meeting
---
identifier: "/us/fr/02-13724"
source: "fr"
legal_status: "authoritative_unofficial"
title: "National Institute of Neurological Disorders and Stroke; Amended Notice of Meeting"
title_number: 0
title_name: "Federal Register"
section_number: "02-13724"
section_name: "National Institute of Neurological Disorders and Stroke; Amended Notice of Meeting"
positive_law: false
currency: "2002-05-31"
last_updated: "2002-05-31"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "02-13724"
document_type: "notice"
publication_date: "2002-05-31"
agencies:
- "Health and Human Services Department"
- "National Institutes of Health"
fr_citation: "67 FR 38136"
fr_volume: 67
---
# National Institute of Neurological Disorders and Stroke; Amended Notice of Meeting
Notice is hereby given of a change in the meeting of the National Advisory Neurological Disorders and Stroke Council, May 30, 2002, 8:00 a.m. to May 30, 2002, 10:00 a.m., National Institutes of Health, Building 31, A Wing, Conference Room 8A28, 31 Center Drive, Bethesda, MD, 20892, which was published in the *Federal Register* on May 2, 2002, 67 FR 02-10911.
The location of the Clinical Trials Subcommittee meeting has been changed to Building 31, Conference Room 10, The meeting is partially Closed to the public.
Dated: May 24, 2002.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.